It inhibited NF-κB in an acute model of lung inflammation induced by LPS and hence decreased inflammatory cell infiltration into the lung tissue and the release of pro-inflammatory cytokines in the alveolar space [59]. The gene discussed is NFKB1; the disease is inflammation.